Clinical impact of the use of 16S rRNA sequencing method for the identification of "difficult-to-identify" bacteria in immunocompromised hosts.
about
Brain abscess caused by Nocardia asiaticaCatheter-related bloodstream infection by Tsukamurella inchonensis in an immunocompromised patient.Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?Differentiation between Nocardia spp. and Mycobacterium spp.: Critical aspects for bacteriological diagnosis.The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science.Direct sequencing and RipSeq interpretation as a tool for identification of polymicrobial infectionsRhodococcus fascians infection after haematopoietic cell transplantation: not just a plant pathogen?Rhodococcus globerulus bacteremia in an allogeneic hematopoietic stem cell transplant recipient: report of the first transplant case and review of the literature.Gordonia terrae kidney graft abscess in a renal transplant patient.
P2860
Q28830987-E5484334-B2DA-4093-AC75-646FD9EDCC19Q33703508-C956ADB8-1879-48F1-B3BC-5F80B8B78576Q33776974-F1DE32F9-5626-42AE-82C2-E6C5526701E5Q34230021-15E7C5B9-17FC-4137-A335-F38303BC7765Q36295051-640CB1FF-134D-4B0F-A6FF-E191F5F38EE3Q36884385-1D725D97-6B75-49E4-BA3E-8774B2BA50E8Q37671544-C90DD2A2-35C6-421D-80DF-8F6035BFDE4EQ38209437-AFA2D6E9-C4E5-4C7C-944D-04ABABA921E9Q42208944-4002D98A-C6BD-4897-A49C-8D6EFD68E9B1
P2860
Clinical impact of the use of 16S rRNA sequencing method for the identification of "difficult-to-identify" bacteria in immunocompromised hosts.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Clinical impact of the use of ...... ia in immunocompromised hosts.
@en
Clinical impact of the use of ...... ia in immunocompromised hosts.
@nl
type
label
Clinical impact of the use of ...... ia in immunocompromised hosts.
@en
Clinical impact of the use of ...... ia in immunocompromised hosts.
@nl
prefLabel
Clinical impact of the use of ...... ia in immunocompromised hosts.
@en
Clinical impact of the use of ...... ia in immunocompromised hosts.
@nl
P2093
P2860
P1476
Clinical impact of the use of ...... ia in immunocompromised hosts.
@en
P2093
H Salimnia
P H Chandrasekar
R Bharadwaj
S Swaminathan
P2860
P304
P356
10.1111/J.1399-3062.2011.00687.X
P577
2011-10-28T00:00:00Z